The GTN patch: a simple and effective new approach to cardioprotection?

Basic Research in Cardiology

Volumn 113, Issue 3, 2018, Pages

  Yellon, Derek M ^a   He, Zhenhe ^a   Khambata, Rayomand ^b   Ahluwalia, Amrita ^b   Davidson, Sean M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cardioprotection; Ischaemia; Mouse; Nitrate; Nitric oxide; Reperfusion

Indexed keywords

GLYCERYL TRINITRATE; NITRATE; NITRIC OXIDE; NITRITE; NITRIC OXIDE DONOR; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; C57BL 6 MOUSE; CONTROLLED STUDY; CORONARY ARTERY OCCLUSION; CORONARY REPERFUSION; DRUG BLOOD LEVEL; DRUG EFFICACY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VIVO STUDY; ISCHEMIC PRECONDITIONING; MALE; MEAN ARTERIAL PRESSURE; MOUSE; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NONHUMAN; REPERFUSION INJURY; ANIMAL; BLOOD; BLOOD PRESSURE; C57BL MOUSE; CUTANEOUS DRUG ADMINISTRATION; DISEASE MODEL; DRUG EFFECT; HEART INFARCTION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TIME FACTOR; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; MALE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE DONORS; NITRITES; NITROGLYCERIN; TIME FACTORS; TRANSDERMAL PATCH; VASODILATOR AGENTS;

EID: 85045668340     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-018-0681-2     Document Type: Article

References (37)

1. Baker JE, Su J, Fu X, Hsu A, Gross GJ, Tweddell JS, Hogg N (2007) Nitrite confers protection against myocardial infarction: role of xanthine oxidoreductase, NADPH oxidase and K(ATP) channels. J Mol Cell Cardiol 43:437–444. https://doi.org/10.1016/j.yjmcc.2007.07.057
2. Bice JS, Jones BR, Chamberlain GR, Baxter GF (2016) Nitric oxide treatments as adjuncts to reperfusion in acute myocardial infarction: a systematic review of experimental and clinical studies. Basic Res Cardiol 111:23. https://doi.org/10.1007/s00395-016-0540-y
3. Bromage DI, Pickard JM, Rossello X, Ziff OJ, Burke N, Yellon DM, Davidson SM (2017) Remote ischaemic conditioning reduces infarct size in animal in vivo models of ischaemia-reperfusion injury: a systematic review and meta-analysis. Cardiovasc Res 113:288–297. https://doi.org/10.1093/cvr/cvw219
4. Bush PA, Gonzalez NE, Griscavage JM, Ignarro LJ (1992) Nitric oxide synthase from cerebellum catalyzes the formation of equimolar quantities of nitric oxide and citrulline from l-arginine. Biochem Biophys Res Commun 185:960–966
5. Csont T, Ferdinandy P (2005) Cardioprotective effects of glyceryl trinitrate: beyond vascular nitrate tolerance. Pharmacol Ther 105:57–68. https://doi.org/10.1016/j.pharmthera.2004.10.001
6. Davidson SM, Yellon DM (2018) Cardioprotection—is NO the answer? A renewed look at nitric oxide signalling in cardiomyocytes. Cardiovasc Res. https://doi.org/10.1093/cvr/cvy073 (in press)
7. Duranski MR, Greer JJ, Dejam A, Jaganmohan S, Hogg N, Langston W, Patel RP, Yet SF, Wang X, Kevil CG, Gladwin MT, Lefer DJ (2005) Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Investig 115:1232–1240. https://doi.org/10.1172/JCI22493
8. Frankenreiter S, Bednarczyk P, Kniess A, Bork NI, Straubinger J, Koprowski P, Wrzosek A, Mohr E, Logan A, Murphy MP, Gawaz M, Krieg T, Szewczyk A, Nikolaev VO, Ruth P, Lukowski R (2017) cGMP-elevating compounds and ischemic conditioning provide cardioprotection against ischemia and reperfusion injury via cardiomyocyte-specific BK channels. Circulation 136:2337–2355. https://doi.org/10.1161/CIRCULATIONAHA.117.028723
9. Frankenreiter S, Groneberg D, Kuret A, Krieg T, Ruth P, Friebe A, Lukowski R (2018) Cardioprotection by ischemic postconditioning and cGMP-elevating agents involves cardiomyocyte nitric oxide-sensitive guanylyl cyclase. Cardiovasc Res. https://doi.org/10.1093/cvr/cvy039
10. Hauerslev M, Mork SR, Pryds K, Contractor H, Hansen J, Jespersen NR, Johnsen J, Heusch G, Kleinbongard P, Kharbanda R, Botker HE, Schmidt MR (2018) Influence of long-term treatment with glyceryl trinitrate on remote ischemic conditioning. Am J Physiol Heart Circ Physiol. https://doi.org/10.1152/ajpheart.00114.2018
11. Hausenloy DJ, Barrabes JA, Botker HE, Davidson SM, Di Lisa F, Downey J, Engstrom T, Ferdinandy P, Carbrera-Fuentes HA, Heusch G, Ibanez B, Iliodromitis EK, Inserte J, Jennings R, Kalia N, Kharbanda R, Lecour S, Marber M, Miura T, Ovize M, Perez-Pinzon MA, Piper HM, Przyklenk K, Schmidt MR, Redington A, Ruiz-Meana M, Vilahur G, Vinten-Johansen J, Yellon DM, Garcia-Dorado D (2016) Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery. Basic Res Cardiol 111:70. https://doi.org/10.1007/s00395-016-0588-8
12. Hausenloy DJ, Baxter G, Bell R, Botker HE, Davidson SM, Downey J, Heusch G, Kitakaze M, Lecour S, Mentzer R, Mocanu MM, Ovize M, Schulz R, Shannon R, Walker M, Walkinshaw G, Yellon DM (2010) Translating novel strategies for cardioprotection: the Hatter workshop recommendations. Basic Res Cardiol 105:677–686. https://doi.org/10.1007/s00395-010-0121-4
13. Hausenloy DJ, Garcia-Dorado D, Botker HE, Davidson SM, Downey J, Engel FB, Jennings R, Lecour S, Leor J, Madonna R, Ovize M, Perrino C, Prunier F, Schulz R, Sluijter JPG, Van Laake LW, Vinten-Johansen J, Yellon DM, Ytrehus K, Heusch G, Ferdinandy P (2017) Novel targets and future strategies for acute cardioprotection: position paper of the European Society of Cardiology Working Group on cellular biology of the heart. Cardiovasc Res 113:564–585. https://doi.org/10.1093/cvr/cvx049
14. Hausenloy DJ, Kharbanda R, Rahbek Schmidt M, Moller UK, Ravkilde J, Okkels Jensen L, Engstrom T, Garcia Ruiz JM, Radovanovic N, Christensen EF, Sorensen HT, Ramlall M, Bulluck H, Evans R, Nicholas J, Knight R, Clayton T, Yellon DM, Botker HE (2015) Effect of remote ischaemic conditioning on clinical outcomes in patients presenting with an ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Eur Heart J 36:1846–1848. https://doi.org/10.1093/eurheartj/ehv249
15. Hausenloy DJ, Yellon DM (2016) Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol 13:193–209. https://doi.org/10.1038/nrcardio.2016.5
16. Hendgen-Cotta UB, Merx MW, Shiva S, Schmitz J, Becher S, Klare JP, Steinhoff HJ, Goedecke A, Schrader J, Gladwin MT, Kelm M, Rassaf T (2008) Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury. Proc Natl Acad Sci USA 105:10256–10261. https://doi.org/10.1073/pnas.0801336105
17. Heusch G (2017) Cardioprotection is alive but remains enigmatic: the nitric oxide–protein kinases–mitochondria signaling axis. Circulation 136:2356–2358. https://doi.org/10.1161/CIRCULATIONAHA.117.031978
18. Heusch G (2001) Nitroglycerin and delayed preconditioning in humans: yet another new mechanism for an old drug? Circulation 103:2876–2878
19. Hill M, Takano H, Tang XL, Kodani E, Shirk G, Bolli R (2001) Nitroglycerin induces late preconditioning against myocardial infarction in conscious rabbits despite development of nitrate tolerance. Circulation 104:694–699. https://doi.org/10.1161/hc3201.092218
20. Ignarro LJ, Fukuto JM, Griscavage JM, Rogers NE, Byrns RE (1993) Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from l-arginine. Proc Natl Acad Sci USA 90:8103–8107. https://doi.org/10.1073/pnas.90.17.8103
21. Jones DA, Pellaton C, Velmurugan S, Rathod KS, Andiapen M, Antoniou S, van Eijl S, Webb AJ, Westwood MA, Parmar MK, Mathur A, Ahluwalia A (2015) Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction. Circ Res 116:437–447. https://doi.org/10.1161/CIRCRESAHA.116.305082
22. Kleinbongard P, Dejam A, Lauer T, Jax T, Kerber S, Gharini P, Balzer J, Zotz RB, Scharf RE, Willers R, Schechter AN, Feelisch M, Kelm M (2006) Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans. Free Radic Biol Med 40:295–302. https://doi.org/10.1016/j.freeradbiomed.2005.08.025
23. Kleinbongard P, Thielmann M, Jakob H, Peters J, Heusch G, Kottenberg E (2013) Nitroglycerin does not interfere with protection by remote ischemic preconditioning in patients with surgical coronary revascularization under isoflurane anesthesia. Cardiovasc Drugs Ther 27:359–361. https://doi.org/10.1007/s10557-013-6451-3
24. Leesar MA, Stoddard MF, Dawn B, Jasti VG, Masden R, Bolli R (2001) Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty. Circulation 103:2935–2941
25. Liu X, Huang Y, Pokreisz P, Vermeersch P, Marsboom G, Swinnen M, Verbeken E, Santos J, Pellens M, Gillijns H, Van de Werf F, Bloch KD, Janssens S (2007) Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion. J Am Coll Cardiol 50:808–817. https://doi.org/10.1016/j.jacc.2007.04.069
26. Mikhed Y, Fahrer J, Oelze M, Kroller-Schon S, Steven S, Welschof P, Zinssius E, Stamm P, Kashani F, Roohani S, Kress JM, Ullmann E, Tran LP, Schulz E, Epe B, Kaina B, Munzel T, Daiber A (2016) Nitroglycerin induces DNA damage and vascular cell death in the setting of nitrate tolerance. Basic Res Cardiol 111:52. https://doi.org/10.1007/s00395-016-0571-4
27. Nagasaka Y, Fernandez BO, Garcia-Saura MF, Petersen B, Ichinose F, Bloch KD, Feelisch M, Zapol WM (2008) Brief periods of nitric oxide inhalation protect against myocardial ischemia-reperfusion injury. Anesthesiology 109:675–682. https://doi.org/10.1097/ALN.0b013e318186316e
28. Pickard JM, Botker HE, Crimi G, Davidson B, Davidson SM, Dutka D, Ferdinandy P, Ganske R, Garcia-Dorado D, Giricz Z, Gourine AV, Heusch G, Kharbanda R, Kleinbongard P, MacAllister R, McIntyre C, Meybohm P, Prunier F, Redington A, Robertson NJ, Suleiman MS, Vanezis A, Walsh S, Yellon DM, Hausenloy DJ (2015) Remote ischemic conditioning: from experimental observation to clinical application: report from the 8th Biennial Hatter Cardiovascular Institute Workshop. Basic Res Cardiol 110:453. https://doi.org/10.1007/s00395-014-0453-6
29. Rassaf T, Totzeck M, Hendgen-Cotta UB, Shiva S, Heusch G, Kelm M (2014) Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning. Circ Res 114:1601–1610. https://doi.org/10.1161/CIRCRESAHA.114.303822
30. Salloum FN, Takenoshita Y, Ockaili RA, Daoud VP, Chou E, Yoshida K, Kukreja RC (2007) Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits. J Mol Cell Cardiol 42:453–458. https://doi.org/10.1016/j.yjmcc.2006.10.015
31. Schulz R, Kelm M, Heusch G (2004) Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res 61:402–413. https://doi.org/10.1016/j.cardiores.2003.09.019
32. Shiva S, Sack MN, Greer JJ, Duranski M, Ringwood LA, Burwell L, Wang X, MacArthur PH, Shoja A, Raghavachari N, Calvert JW, Brookes PS, Lefer DJ, Gladwin MT (2007) Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med 204:2089–2102. https://doi.org/10.1084/jem.20070198
33. Siddiqi N, Neil C, Bruce M, MacLennan G, Cotton S, Papadopoulou S, Feelisch M, Bunce N, Lim PO, Hildick-Smith D, Horowitz J, Madhani M, Boon N, Dawson D, Kaski JC, Frenneaux M, Investigators N (2014) Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI). Eur Heart J 35:1255–1262. https://doi.org/10.1093/eurheartj/ehu096
34. Siervo M, Lara J, Ogbonmwan I, Mathers JC (2013) Inorganic nitrate and beetroot juice supplementation reduces blood pressure in adults: a systematic review and meta-analysis. J Nutr 143:818–826. https://doi.org/10.3945/jn.112.170233
35. Szilvassy Z, Ferdinandy P, Nagy I, Jakab I, Koltai M (1997) The effect of continuous versus intermittent treatment with transdermal nitroglycerin on pacing-induced preconditioning in conscious rabbits. Br J Pharmacol 121:491–496. https://doi.org/10.1038/sj.bjp.0701163
36. Totzeck M, Hendgen-Cotta UB, Rassaf T (2017) Nitrite-nitric oxide signaling and cardioprotection. Adv Exp Med Biol 982:335–346. https://doi.org/10.1007/978-3-319-55330-6_18
37. Tripathi Y, Hegde BM, Raghuveer CV (1997) Effect of superoxide dismutase and acidified sodium nitrite on infarct size following ischemia and reperfusion in dogs. Indian J Physiol Pharmacol 41:248–256